泰诺麦博-U(688806)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688806 泰诺麦博-U

已收盘 09-30 15:00:00

{"stockData":{"symbol":"688806","market":"SH","secType":"STK","nameCN":"泰诺麦博-U","latestPrice":30.67,"timestamp":1790751600000,"preClose":25.56,"halted":0,"volume":12037504,"delay":0,"changeRate":0.1999,"floatShares":51025700,"shares":461000000,"eps":-1.1086,"marketStatus":"已收盘","change":5.11,"latestTime":"09-30 15:00:00","open":25.35,"high":30.67,"low":25.35,"amount":351000000,"amplitude":0.2081,"askPrice":0,"askSize":0,"bidPrice":30.67,"bidSize":11602,"shortable":0,"etf":0,"ttmEps":-1.1086,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":25.56,"symbolType":"stock_kcb","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":28.12,"lowLimit":23,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":460546190,"isCdr":false,"pbRate":275.02,"roa":"--","roe":"--","epsLYR":-1.56,"committee":0,"marketValue":14125000000,"turnoverRate":0.2359,"status":0,"afterMarket":{"amount":36804,"volume":1200,"close":30.67,"buyVolume":97712,"sellVolume":0,"time":1790753637746,"indexStatus":"已收盘 09-30 15:30:00","preClose":25.56},"floatMarketCap":1565000000},"requestUrl":"/m/hq/s/688806/tweets","defaultTab":"tweets","newsList":[{"id":"2671221568","title":"异动快报：泰诺麦博-U（688806）9月30日9点57分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2671221568","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671221568?lang=zh_cn&edition=full","pubTime":"2026-09-30 10:01","pubTimestamp":1790733662,"startTime":"0","endTime":"0","summary":"证券之星9月30日盘中消息，9点57分泰诺麦博-U（688806）触及涨停板。其所属行业生物制品目前上涨。领涨股为康希诺。该股为创新药，医药概念热股，当日创新药概念上涨2.49%，医药概念上涨2.34%。9月29日的资金流向数据方面，主力资金净流入295.14万元，占总成交额1.59%，游资资金净流入582.52万元，占总成交额3.14%，散户资金净流出877.66万元，占总成交额4.73%。近5日资金流向一览见下表：泰诺麦博-U主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000010321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688806"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671251782","title":"泰诺麦博（688806）9月29日主力资金净买入295.14万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671251782","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671251782?lang=zh_cn&edition=full","pubTime":"2026-09-30 08:26","pubTimestamp":1790727973,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月29日收盘，泰诺麦博报收于25.56元，下跌4.84%，换手率14.09%，成交量7.19万手，成交额1.86亿元。近5日资金流向一览见下表：泰诺麦博融资融券信息显示，融资方面，当日融资买入2563.37万元，融资偿还1217.05万元，融资净买入1346.33万元。泰诺麦博主营业务：全人源抗体药物的开发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000006633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688806"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670235665","title":"泰诺麦博（688806）披露中证中小投资者服务中心就选举独立董事事项公开征集投票权，9月28日股价上涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670235665","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670235665?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:52","pubTimestamp":1790589154,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘，泰诺麦博报收于26.86元，较前一交易日上涨5.33%，最新总市值为123.7亿元。该股当日开盘25.54元，最高27.44元，最低24.56元，成交额达2.13亿元，换手率为15.98%。近日，泰诺麦博披露《关于中证中小投资者服务中心有限责任公司公开征集投票权的公告》。公告显示，中证中小投资者服务中心有限责任公司作为征集人，就珠海泰诺麦博制药股份有限公司2026年第三次临时股东会审议的《关于选举第二届董事会独立董事的议案》公开征集投票权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800023471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688806"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669432272","title":"泰诺麦博（688806）9月23日主力资金净买入2362.53万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669432272","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669432272?lang=zh_cn&edition=full","pubTime":"2026-09-24 08:18","pubTimestamp":1790209123,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月23日收盘，泰诺麦博报收于26.46元，上涨3.6%，换手率19.18%，成交量9.79万手，成交额2.58亿元。近5日资金流向一览见下表：泰诺麦博融资融券信息显示，融资方面，当日融资买入1777.61万元，融资偿还1922.36万元，融资净偿还144.75万元。泰诺麦博主营业务：全人源抗体药物的开发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400007717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688806"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667638389","title":"股市必读：泰诺麦博（688806）9月11日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2667638389","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667638389?lang=zh_cn&edition=full","pubTime":"2026-09-14 03:03","pubTimestamp":1789326194,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，泰诺麦博报收于20.11元，下跌2.94%，换手率5.98%，成交量3.05万手，成交额6129.85万元。截至2026年6月底，公司首款产品斯泰度塔单抗注射液（新替妥）依托2026年国家医保目录落地红利，已覆盖1,800余家医疗机构，渗透率持续提升，2026年上半年实现营业收入7,624.10万元，较上年同期增长623.41%。当日关注点交易信息汇总：9月11日主力资金净流出394.03万元，占总成交额6.43%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688806"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666597449","title":"股市必读：泰诺麦博（688806）9月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2666597449","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666597449?lang=zh_cn&edition=full","pubTime":"2026-09-11 01:15","pubTimestamp":1789060512,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，泰诺麦博报收于20.72元，下跌4.38%，换手率6.34%，成交量3.24万手，成交额6773.91万元。董秘最新回复投资者： 董秘您好，目前公司创新药在研项目共有几种？是全球首款一针给药即可拥有长达9个月临床保护数据的RSV单抗。本品最终于 2026 年 9 月获批上市，自申请受理至获准上市历时约 7 个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688806"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665536544","title":"每周股票复盘：泰诺麦博（688806）新多妥®获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2665536544","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665536544?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:18","pubTimestamp":1788632293,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，泰诺麦博报收于23.04元，较上周的24.15元下跌4.6%。本周，泰诺麦博9月4日盘中最高价报25.53元。公司公告汇总珠海泰诺麦博制药股份有限公司自主研发的1类儿童专用创新药芮特韦拜单抗注射液获国家药品监督管理局批准上市，适用于新生儿和婴儿预防呼吸道合胞病毒所致下呼吸道感染。关键III期临床试验证实其对需就医和住院的RSV下呼吸道感染保护效力分别为71.3%和71.7%，严重病例保护效力超90%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688806"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664820025","title":"泰诺麦博(688806.SH)：芮特韦拜单抗注射液获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2664820025","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664820025?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:59","pubTimestamp":1788425988,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰诺麦博 发布公告，公司收到国家药品监督管理局通知，通过优先审评审批程序批准公司自主研发的1类儿童专用创新药芮特韦拜单抗注射液上市。作为公司完全自主研发的1类创新药，芮特韦拜单抗注射液项目获国家科技重大专项立项支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","688806"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659175606","title":"每周股票复盘：泰诺麦博（688806）召开临时股东会审议通过多项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2659175606","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659175606?lang=zh_cn&edition=full","pubTime":"2026-08-16 01:28","pubTimestamp":1786814892,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，泰诺麦博报收于27.03元，较上周的28.19元下跌4.11%。本周关注点公司公告汇总：泰诺麦博召开2026年第二次临时股东会，审议通过变更注册资本、修订章程等议案。会议审议通过变更公司注册资本、修订公司章程、制定董事和高管薪酬管理制度、购买董事及高管责任险等议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688806"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659147835","title":"泰诺麦博（688806）披露2026年第二次临时股东会决议公告，8月14日股价下跌3.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659147835","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659147835?lang=zh_cn&edition=full","pubTime":"2026-08-14 22:07","pubTimestamp":1786716432,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，泰诺麦博报收于27.03元，较前一交易日下跌3.05%，最新总市值为124.49亿元。近日，珠海泰诺麦博制药股份有限公司披露《2026年第二次临时股东会决议公告》。公告显示，公司于2026年8月14日召开2026年第二次临时股东会，会议由董事会召集，董事长HUAXIN LIAO先生主持，采用现场与网络投票结合方式召开。出席会议股东共589人，代表有表决权股份总数235,850,379股，占公司总表决权股份的51.2110%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400039638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688806"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656316378","title":"每周股票复盘：泰诺麦博（688806）上市首周三次登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2656316378","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656316378?lang=zh_cn&edition=full","pubTime":"2026-08-02 01:34","pubTimestamp":1785605652,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，泰诺麦博报收于24.92元，较上周的26.6元下跌6.32%。本周关注点来自交易信息汇总：泰诺麦博在上市后5个交易日内3次因日换手率达30%登上龙虎榜。交易信息汇总沪深交易所2026年7月28日至30日连续公布交易公开信息，泰诺麦博因有价格涨跌幅限制的日换手率达到30%的前五只证券，连续三日登上龙虎榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200000260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688806"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655206268","title":"7月30日泰诺麦博（688806）龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2655206268","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655206268?lang=zh_cn&edition=full","pubTime":"2026-07-30 17:53","pubTimestamp":1785405226,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月30日公布的交易公开信息显示，泰诺麦博因有价格涨跌幅限制的日换手率达到30%的前五只证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2026年7月30日收盘，泰诺麦博报收于23.47元，下跌13.14%，换手率36.57%，成交量18.66万手，成交额4.64亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000028249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688806"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654888846","title":"泰诺麦博（688806）披露2026年第二次临时股东会通知，7月28日股价下跌8.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654888846","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654888846?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:03","pubTimestamp":1785247381,"startTime":"0","endTime":"0","summary":"截至2026年7月28日收盘，泰诺麦博报收于26.09元，较前一交易日下跌8.49%，最新总市值为120.16亿元。该股当日开盘27.05元，最高29.0元，最低25.88元，成交额达5.2亿元，换手率为37.54%。近日，公司披露《关于召开2026年第二次临时股东会的通知》。公告显示，珠海泰诺麦博制药股份有限公司董事会宣布召开2026年第二次临时股东会，会议将于2026年8月14日14时在公司二楼会议室举行，同时提供网络投票。股权登记日为2026年8月10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800039501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688806"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654300896","title":"7月28日泰诺麦博（688806）龙虎榜数据：机构净买入957.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2654300896","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654300896?lang=zh_cn&edition=full","pubTime":"2026-07-28 17:51","pubTimestamp":1785232294,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月28日公布的交易公开信息显示，泰诺麦博因有价格涨跌幅限制的日换手率达到30%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年7月28日收盘，泰诺麦博报收于26.09元，下跌8.49%，换手率37.54%，成交量19.16万手，成交额5.2亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入957.88万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800029234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688806"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652075256","title":"泰诺麦博(688806.SH)股票将于7月21日在科创板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2652075256","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652075256?lang=zh_cn&edition=full","pubTime":"2026-07-19 15:56","pubTimestamp":1784447805,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰诺麦博(688806.SH)发布公告，公司股票将于2026年7月21日在上海证券交易所科创板上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469402.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688806","KSTR","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650977731","title":"A股申购 | 泰诺麦博(688806.SH)开启申购 全球同类首创的斯泰度塔单抗注射液已获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2650977731","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650977731?lang=zh_cn&edition=full","pubTime":"2026-07-10 06:38","pubTimestamp":1783636684,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，7月10日，泰诺麦博开启申购，发行价格为14.46元/股，申购上限为1.15万股，属于上交所，华泰证券为其保荐机构。其中，全球同类首创的斯泰度塔单抗注射液已获批上市，TNM001以非高危及高危婴儿为适应症人群已递交NDA并获受理、同时已纳入优先审评程序，2款候选药物TNM009及TNM005已完成临床I期试验，1款候选药物TNM006已获批IND，以及3款候选药物处于临床前阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1465624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","688806","399300","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649524995","title":"泰诺麦博(688806.SH)：IPO发行价为14.46元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649524995","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649524995?lang=zh_cn&edition=full","pubTime":"2026-07-08 20:07","pubTimestamp":1783512426,"startTime":"0","endTime":"0","summary":"格隆汇7月8日丨泰诺麦博(688806.SH)公布，发行人和保荐人(主承销商)根据初步询价结果，综合评估公司合理投资价值、可比公司二级市场估值水平、所属行业二级市场估值水平等方面，充分考虑网下投资者有效申购倍数、市场情况、募集资金需求及承销风险等因素，协商确定本次发行价格为14.46元/股，网下发行不再进行累计投标询价。\r\n\r\n　　投资者请按此价格在2026年7月10日(T日)进行网上和网下申购，申购时无需缴付申购资金。本次网下发行申购日与网上申购日同为2026年7月10日(T日)，其中，网下申购时间为9:30-15:00，网上申购时间为9:30-11:30，13:00-15:00。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260708/32302281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["FRHC","KCE","BK4127","IPOS","688806"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790805268987,"stockEarnings":[{"period":"1week","weight":0.1591},{"period":"1month","weight":0.2979},{"period":"3month","weight":1.121},{"period":"ytd","weight":1.121}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"珠海泰诺麦博制药股份有限公司","stockholders":"43772人(较上一季度增加89230.61%)","perCapita":"1165股","listingDate":"2026-07-21","address":"广东省珠海市金湾区珠海大道6366号6#厂房一楼110室","registeredCapital":"46054万元","survey":"　　珠海泰诺麦博制药股份有限公司的主营业务是全人源抗体药物的开发、生产和销售。公司的主要产品是重组抗破伤风毒素全人源单克隆抗体—斯泰度塔单抗注射液、重组抗呼吸道合胞病毒全人源单克隆抗体—芮特韦拜单抗注射液。截至报告期末，公司已形成59项国内外发明专利，并有多项在申请的国内外专利。","listedPrice":14.46},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰诺麦博-U(688806)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰诺麦博-U(688806)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰诺麦博-U,688806,泰诺麦博-U股票,泰诺麦博-U股票老虎,泰诺麦博-U股票老虎国际,泰诺麦博-U行情,泰诺麦博-U股票行情,泰诺麦博-U股价,泰诺麦博-U股市,泰诺麦博-U股票价格,泰诺麦博-U股票交易,泰诺麦博-U股票购买,泰诺麦博-U股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰诺麦博-U(688806)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰诺麦博-U(688806)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}